0.50Open0.50Pre Close0 Volume3 Open Interest35.00Strike Price0.00Turnover426.23%IV105.32%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type0.1358Delta0.0243Gamma34.58Leverage Ratio-0.1732Theta0.0003Rho4.70Eff Leverage0.0046Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet